Search
Filter Results
Displaying 231–240 of 261 for “usher syndrome”
-
Oct 8, 2015
A Leap Forward: Spark Therapeutics Seeks FDA Approval for its Vision-Restoring Gene Therapy
-
Jun 27, 2015
VISIONS 2015 — Dr. José Sahel Receives Foundation's Most Prestigious Research Honor
For those of us supporting the drive for vision-saving treatments and cures, he’s exactly the type of person we want on our team.
-
May 19, 2015
ARVO 2015 Highlight: The National Eye Institute Invests $4 Million in Audacious-Goals Research
The mission of the program—to regenerate the neurons and neural connections in the eye and visual system—is synonymous with the Foundation’s mission to eradicate retinal diseases.
-
Jan 22, 2014
Choroideremia Gene Therapy Improves Vision in Human Study
Researchers were able to improve vision in five of six people with choroideremia participating in a clinical trial.
-
Oct 30, 2013
Urine Test Helps Diagnose RP Caused by DHDDS Mutations
While it isn’t a substitute for a diagnosis through genetic testing, the urine test can verify that a given DHDDS mutation is, in fact, causing RP.
-
Oct 23, 2013
What exactly is gene therapy, and how does it work?
-
Sep 26, 2013
New Imaging Technique May Be Game-Changer for RP Clinical Trials
Known as EZ Width, it holds potential for reducing the time, cost and number of patients needed to determine if a therapy is working in a clinical trial.
-
Jan 10, 2013
Orphan Drugs Get Special Treatment
For developers of treatments for rare diseases — including inherited retinal conditions — “orphan” status provides valuable benefits, such as tax incentives, access to special research grants and assistance with clinical trial design.